Bank Of America Corp Mei Pharma, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $0.35 $2,605 - $4,342	12,408 Added 81.79%	27,579 $6,000
Q4 2022 Feb 10, 2023	BUY	$0.22 - $0.41 $68 - $127	312 Added 2.1%	15,171 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.41 - $0.64 $0 - $1	-2 Reduced 0.01%	14,859 $6,000
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.65 $77 - $119	-184 Reduced 1.22%	14,861 $9,000
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $19,227 - $97,560	-35,606 Reduced 70.3%	15,045 $9,000

Q4 2021 Feb 08, 2022	BUY	$2.33 - $3.37 $74,755 - $108,123	32,084 Added 172.8%	50,651 $135,000
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $2,756 - $3,271	-1,094 Reduced 5.56%	18,567 $51,000
Q2 2021 Sep 13, 2021	BUY	$2.6 - $3.65 $51,118 - $71,762	19,661 New	19,661 $56,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.